Funding Roundup
Cervel Neurotech raises $11M for device-based depression therapy
California-based medical device maker Cervel Neurotech is nearing the close of an $11.9 million funding round, having raised $11.1 million since April 2013 in support of its technology-based therapies for neurological and psychiatric disorders.
Axonia raises $2M in seed funding for nerve repair grafts
Michigan startup Axonia Medical the close of a $2 million seed financing round that the company plans to use to further develop its nerve repair and restoration technologies.
Axonia aims to repair damage associated with nerve injuries, such as peripheral nerve injury, spinal cord injury, traumatic brain injury and stroke, and area with "a remarkable absence of viable treatment options," the company said.
Cheetah Medical adds $5M to coffers
Cheetah Medical said it raised an initial $5 million investment from HighCape Partners for its non-invasive hemodynamic monitoring system.
Newton, Mass.-based Cheetah said the round is an extension of a prior raise that brought in $9 million.
AxoGen and Brigham win $1.9M Pentagon contract for nerve repair innovation
The U.S. Dept. of Defense awarded a pair of grants worth $1.9 million to AxoGen and Brigham and Women’s Hospital in Boston in support of their efforts to develop tools to aid in peripheral nerve surgeries.
Senseonics gains funding for continuous glucose monitoring implant | Medtech funding for the week of June 2, 2014
Diabetes: Senseonics raises $20M for continuous glucose monitoring implant
UPDATED June 5, 2014, with new round total and comment from Senseonics.
Spinal Kinetics reels in $34M, settles patent spat with DePuy Synthes
TAVI: Transcatheter Technologies lands 2nd Series B tranche
Transcatheter Technologies GmbH said it raised the 2nd tranche in its Series B round for its 3rd-generation replacement heart valve.
The tranche takes the German transcatheter aortic heart implant developer’s total raise to nearly $7.2 million, a spokesman told MassDevice.com this morning.
Premia Spine confirms $7M raise for spinal fusion alternative
Israeli device maker Premia Spine confirmed today that it had raised $7 million, planning on using part of the funds to pursue FDA approval for its spinal fixation devices.
CEO Ron Sacher told MassDevice.com today that the reports about the company’s latest fundraising efforts are true, and that Premia is looking to raise another $3 million to close out the financing round.
ALung raises $10M for Hemolung
ALung Technologies said it drummed up another $10 million it plans to use to continue commercializing its Hemolung respiratory assist device.
Pittsburgh-based ALung’s Hemolung device is an extracorporeal carbon dioxide removal system that works by removing carbon dioxide and delivering oxygen directly to a patient’s blood via a small catheter inserted into the jugular or femoral vein.